Editor’s Note March 21, 2012
New York Biotechnology Association (NYBA) has announced that it will develop its Emerging Companies Showcase at the NYBA 21st Annual Meeting, May 2-3 in New […]
Month: March 2012
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
March 13-14, 2012 Barclays Capital Global Healthcare Conference
We are pleased to invite you to attend the Barclays Capital Global Healthcare Conference, to be held Tuesday, March 13 and Wednesday, March 14, 2012, at the Loews Miami Hotel in Miami, Florida.
MPR Associates Discuss Brainstorming in Medical Device Development and wearing “Six Hats”
Cameron Loper and Brian Scrivens of MPR Associates discuss brainstorming and how it can bring a medical device to market.
Polymedix’s antibiotics are designed to imitate the mechanism of natural human immunity
PolyMedix has a pipeline of innovative infectious disease and cardiovascular product candidates.
Rodman & Renshaw Launches DirectMarkets: First-Ever 24/7 Automated Electronic Transaction Platform
Rodman & Renshaw Capital Group, Inc. will unveil an automated state-of-the-art electronic transaction platform to directly link issuers and investors.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
TDI-132 shows promising results in the treatment of ALS
ALS may be the most deadly disease many people have never heard of. Also referred to as Lou Gehrig’s disease, it affects at least 30,000 people in the United States and 450,000 people worldwide.